Saturday, November 14, 2026
The top medical stories of the day, as they ran.
Morning edition
11 stories
- 1CMS gives states six months before enforcing Medicaid work requirementsMedicare and Medicaid · 6 outlets
- 2U.S. loses measles-elimination status after sustained outbreaksInfectious disease · 5 outlets
- 3Microsoft outage disrupts UK health services and public agenciesPublic health · 4 outlets
- 4North Dakota caps patients’ insulin costs at $25 a monthHealth policy · 2 outlets
- 5FDA approves durvalumab and enfortumab for muscle invasive bladder cancerDrugs and FDA · 2 outlets
- 6Study finds stopping statins noninferior for some older adults without CVDResearch · 1 outlet
- 7bioQuad recalls OsteoDenx supplements over undeclared milkRecalls · 1 outlet
- 8FDA approves Gazyva for adults with primary membranous nephropathyDrugs and FDA · 1 outlet
- 9Medline updates repair and replacement program for recalled beds and accessoriesRecalls · 1 outlet
- 10Study finds tau fragment may help identify advanced CTEResearch · 2 outlets
- 11Macleods recalls combination blood-pressure tablets over dissolution failuresDrug safety · 1 outlet
Evening edition
14 stories
- 1Trump administration delays enforcement of Medicaid work requirementsMedicare and Medicaid · 7 outlets
- 2U.S. loses measles elimination status after yearlong transmissionInfectious disease · 9 outlets
- 3American Cancer Society recommends prostate screening every 2 years from age 50Cancer · 2 outlets
- 4Microsoft outage disrupts UK health services and public agenciesPublic health · 3 outlets
- 5Study finds combining BMI with waist measures improves obesity assessmentDiabetes and obesity · 2 outlets
- 6Early dupilumab use linked to fewer asthma diagnoses in children with EoEResearch · 2 outlets
- 7FDA approves durvalumab and enfortumab for muscle invasive bladder cancerDrugs and FDA · 2 outlets
- 8Israeli strike on Nasser Hospital kills six, including surgeonHospitals · 2 outlets
- 9bioQuad recalls OsteoDenx supplements over undeclared milkRecalls · 1 outlet
- 10FDA approves Gazyva for adults with primary membranous nephropathyDrugs and FDA · 1 outlet
- 11Study finds ice baths eased soreness but did not speed muscle strength recoveryResearch · 2 outlets
- 12Study finds tau fragment may help identify advanced CTEResearch · 2 outlets
- 13Medline updates repair and replacement program for recalled beds and accessoriesRecalls · 1 outlet
- 14Macleods recalls combination blood-pressure tablets over dissolution failuresDrug safety · 1 outlet